News

News

We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees

Oxford spinout’s diagnostic tests take just weeks to develop

25th July 2016
All News | Spin-Outs & Start-Ups

A technology co-developed at the Universities of Oxford and Sao Paulo State University in Brazil will be commercialised by spinout OID (Oxford Impedance Diagnostics), offering the potential for ultrasensitive fast diagnostic tests for a range of diseases.

Read more

Oxford Technology Showcase: Big Healthcare Challenges in Chronic Disease

7th July 2016
All News | Spin-Outs & Start-Ups | Technology News

The fourth annual Oxford Technology Showcase was held on Wednesday 6th July at Oxford’s Saïd Business School. The event brought together experts and innovators from Oxford University, the Oxford University Hospital Trust and the Oxfordshire region. Over 300 investors, entrepreneurs, healthcare companies, researchers and clinicians attended.

Read more

From Oxbridge research to city investors

20th June 2016
All News

The latest technologies stemming from research at Oxford and Cambridge were presented Tuesday to investors at an event held at the Royal Society of Chemistry. With 17 spinouts already this calendar year, the two universities report that a similar joint event last year led directly to investment in several of the ventures that presented.

Read more

Oxford University Innovation – the new name for Isis Innovation

7th June 2016
All News

Isis Innovation will be renamed Oxford University Innovation, in order to enhance the already strong links between Isis Innovation and the University1. This will strengthen awareness of the company and its services within the wider University, and better portray the University’s ownership of the company.

Read more

Oxford spinout raises £10m for precision system to treat disease

10th May 2016
All News | Spin-Outs & Start-Ups

Oxford spinout EvOx Therapeutics will harness the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.

Read more

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation